VITT

• Ontario researchers find how some COVID-19 vaccines can trigger blood clots

  A group of McMaster University researchers has discovered how certain COVID-19 vaccines can trigger a rare, but sometimes fatal blood-clotting reaction in some recipients.

  Health

  Jul 8
• Hamilton researchers have recommended treatment for rare blood clotting

  A group of McMaster researchers have recently been studying an affliction that's been connected to some vaccine-related blood clots.

  Health

  Jun 11
• Advertisement
• Ontario reports 1st fatal case of rare blood clot after man received AstraZeneca COVID-19 vaccine

  "While the investigation is ongoing and a final cause of death has yet to be officially determined, it has been confirmed the official did have VITT at the time of his death."

  Health

  May 25
• Advertisement
• Rate of COVID-19 vaccine-related blood clots may be as high as 1 in 55,000: NACI

  The National Advisory Committee on Immunization said the current rate of VITT as of May 12 is close to one in 83,000 doses administered.

  Health

  May 21
• A look at what we know about VITT, the rare blood clotting disorder

  VITT continues to draw significant attention, but experts maintain the event is exceedingly rare -- and treatable, in most cases.

  Canada

  May 16
• 2nd person in B.C. diagnosed with rare blood clot disorder following AstraZeneca vaccine

  This is now the second case of vaccine-induced immune thrombotic thrombocytopenic, or VITT, that officials have seen since beginning the COVID-19 vaccine program. 

  Health

  May 13
• Woman diagnosed with B.C.’s first rare blood clot disorder following AstraZeneca vaccine

  This rare clotting disorder can affect someone between day four and day 28 after receiving the vaccine, Dr. Bonnie Henry said at a briefing Thursday.

  Health

  May 6
• Alberta woman dies of complications after receiving AstraZeneca COVID-19 vaccine

  Family confirmed to Global News that the woman who died was 52-year-old Lisa Stonehouse. 

  Health

  May 5